Further, in NSCLC explant models, although TIM-3 blockade alone had a limited effect on tumor growth, the combined blockade of TIM-3 and PD-1 augmented immune function and resulted in antitumor responses (21, 29, 30). Here, HAVCR2 is linked to non-small cell lung carcinoma.